Biblio
“Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.”, J Alzheimers Dis, vol. 70, no. s1, pp. S221-S237, 2019.
, “The MemTrax Test Compared to the Montreal Cognitive Assessment Estimation of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 67, no. 3, pp. 1045-1054, 2019.
, “A Meta-Analysis of Alzheimer's Disease Brain Transcriptomic Data.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1635-1656, 2019.
, “Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.”, J Alzheimers Dis, vol. 68, no. 1, pp. 357-365, 2019.
, “Midlife Insulin Resistance as a Predictor for Late-Life Cognitive Function and Cerebrovascular Lesions.”, J Alzheimers Dis, vol. 72, no. 1, pp. 215-228, 2019.
, “Mild Cognitive Impairment and Dementia Involving Multiple Cognitive Domains in Mexican Urbanites.”, J Alzheimers Dis, vol. 68, no. 3, pp. 1113-1123, 2019.
, “Mitophagy Failure in APP and Tau Overexpression Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 70, no. 2, pp. 525-540, 2019.
, “Modifiable Risk Factors Discriminate Memory Trajectories in Non-Demented Aging: Precision Factors and Targets for Promoting Healthier Brain Aging and Preventing Dementia.”, J Alzheimers Dis, vol. 70, no. s1, pp. S101-S118, 2019.
, “Molecular Basis of Alzheimer's Disease: Focus on Mitochondria.”, J Alzheimers Dis, vol. 72, no. s1, pp. S95-S116, 2019.
, “Neurodegenerative Disease-Related Proteins within the Epidermal Layer of the Human Skin.”, J Alzheimers Dis, vol. 69, no. 2, pp. 463-478, 2019.
, “Neuronal Exosome-Derived Human Tau is Toxic to Recipient Mouse Neurons in vivo.”, J Alzheimers Dis, vol. 67, no. 2, pp. 541-553, 2019.
, “Neuron-Specific Apolipoprotein E4 (1-272) Fragment Induces Tau Hyperphosphorylation and Axonopathy via Triggering Endoplasmic Reticulum Stress.”, J Alzheimers Dis, vol. 71, no. 2, pp. 597-611, 2019.
, “Neuropsychological Deficit Profiles, Vascular Risk Factors, and Neuropathological Findings in Hispanic Older Adults with Autopsy-Confirmed Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 1, pp. 291-302, 2019.
, “NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats.”, J Alzheimers Dis, vol. 73, no. 2, pp. 723-739, 2019.
, “O-GlcNAcylation of Amyloid-β Protein Precursor by Insulin Signaling Reduces Amyloid-β Production.”, J Alzheimers Dis, vol. 69, no. 4, pp. 1195-1211, 2019.
, “Ovariectomy Influences Cognition and Markers of Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 2, pp. 529-541, 2019.
, “The Pathology of Rapid Cognitive Decline in Clinically Diagnosed Alzheimer's Disease.”, J Alzheimers Dis, vol. 70, no. 4, pp. 983-993, 2019.
, “Porphyromonas gingivalis Infection Induces Amyloid-β Accumulation in Monocytes/Macrophages.”, J Alzheimers Dis, vol. 72, no. 2, pp. 479-494, 2019.
, “Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 3, pp. 969-981, 2019.
, “Present Algorithms and Future Treatments for Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 4, pp. 1157-1171, 2019.
, “The Prevalence and Subtypes of Young Onset Dementia in Central Norway: A Population-Based Study.”, J Alzheimers Dis, vol. 69, no. 2, pp. 479-487, 2019.
, “Putative Survival Advantages in Young Apolipoprotein ɛ4 Carriers are Associated with Increased Neural Stress.”, J Alzheimers Dis, vol. 68, no. 3, pp. 885-923, 2019.
, “Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 3, pp. 979-991, 2019.
, “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.”, J Alzheimers Dis, vol. 67, no. 2, pp. 555-570, 2019.
, “Remembering Robert D. Terry at a Time of Change in the World of Alzheimer's Disease.”, J Alzheimers Dis, vol. 70, no. 3, pp. 621-628, 2019.
,